Risk-Reward With Gilead Sciences
Even with a 3% dividend yield, the stock is too expensiveCheck out Jim S.....»»
Gilead, Galapagos drug fails in Phase 3 clinical study
Shares of Gilead Sciences Inc. were down 0.1% in premarket trading on Thursday, the day after the company said an experimental idiopathic pulmonary fibrosis drug it was developing with Galapagos failed a Phase 3 clinical trial. Shares o.....»»
$116 million call spread bought in Tesla with 50/50 risk reward
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Short selling is a high-risk but high-reward trading strategy that profits from a stock price"s fall
Short sel.....»»
Earnings Results: Gilead stock rallies as it reports $1.9 billion in sales for its COVID-19 drug in Q4
Shares of Gilead Sciences Inc.'s stock gained 2.1% in after-hours trading on Thursday after the drug maker surprised investors with better-than-expected sales of its COVID-19 drug Veklury during the fourth quarter of 2020......»»
American Airlines downgraded on balanced risk/reward at Seaport
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Barclays downgrades Canada Goose on unfavorable risk/reward after rally
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead buys more Arcus Biosciences stock, at a price above the record close
Arcus Biosciences Inc. disclosed Monday that Gilead Sciences Inc. boosted its stake in the oncology-focused biopharmaceutical company, through the purchase of $220.35 million worth of stock. Arcus shares were still inactive in pr.....»»
Gritstone Oncology shares soar 44% premarket on news of collaboration with Gilead to develop HIV therapy
Shares of Gritstone Oncology Inc. soared 44% in premarket trade Monday, after the company unveiled an agreement with Gilead Sciences Inc. to us.....»»
Helen of Troy downgraded to Perform at Oppenheimer on balanced risk/reward
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Pinduoduo downgraded to Sector Weight at KeyBanc on balanced risk/reward
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Marathon Petroleum started with Neutral at UBS on balanced risk-reward
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
UBS sees "golden" risk reward for McDonald"s
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead Sciences upgraded to overweight at Morgan Stanley
This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news......»»
Entercom upgraded to Overweight at Wells Fargo on compelling risk/reward
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Wells Fargo risk/reward remains attractive, says Baird
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»
Gilead Sciences Raises FY Guidance Due To Remdesivir Sales
CNBC Exclusive: CNBC Transcript: Gilead Sciences Chairman & CEO Daniel O.....»»
Gilead updates 2020 guidance to raise sales outlook, tighten and lower top end of EPS range
Gilead Sciences Inc. updated its guidance for 2020 on Monday, raising its outlook for sales to reflect sales of COVID-19 treatment.....»»
3 reasons why the stock market is vulnerable to a sharp sell-off, according to Morgan Stanley
"We must acknowledge that the 'risk reward' of the US equity market has deteriorated materially and the market is ripe for a drawdown," said Morgan Stanley's Mike Wilson. .....»»
How Iran is pursuing a high-risk/high-reward strategy to gain an edge in talks with Biden
An uptick in Iranian nuclear and naval activity is part of an effort to make sure the Biden administration prioritizes negotiations with Tehran. Iranian Revolutionary Guard members a.....»»
VistaGen upgraded on "clearly skewed" risk/reward at William Blair
See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»